Efficacy of an inhibitor of GSK‐3β in an Alzheimer’s Disease Mouse Model
Our novel inhibitor of GSK-3β (ING-135), improves cognitive decline (long-term memory) and decreases tau phosphorylation in treated animals versus controls, in the absence of toxicity.
Authors
- Alan P. Kozikowski (ORCID: https://orcid.org/0000-0003-4795-5368)
- Mobeena Ghuman
- Allal Boutajangout (ORCID: https://orcid.org/0000-0002-9582-5675)
- Thomas Wisniewski
- Alsayed Omar Alsayed Atta
- Rim El Kaddioui
Institutions
- NYU Langone Health (US)
- New York University (US)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1002/alz.093368
- Primary Topic
- Alzheimer's disease research and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00